Daily Archives: January 7, 2019

DXB Welcomes Billionth Passenger

DUBAI, United Arab Emirates, Jan. 07, 2019 (GLOBE NEWSWIRE) — Following the official announcement earlier today from HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President & Prime Minister of the UAE and Ruler of Dubai, Dubai Airports and representatives

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

Ongoing endometrial and colorectal cancer cohorts intended to support BLA submissions NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments

Favored Tech Previews Groundbreaking Electronic Coating Tech at CES19

Patented Technology Makes Cell Phones Virtually Water Proof, Offers Comprehensive Protective Nano Coating for the Latest Electronic Devices LAS VEGAS, Jan. 07, 2019 (GLOBE NEWSWIRE) — Favored Tech, a leading provider for the next generation of multi-functional Nano Protection technology

Fertin Pharma Acquires Tab Labs – Provides the Combined Group a Unique CDMO Position in the North American Dietary Supplement Market

VEJLE, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) — Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of Tab Labs Inc. (“Tab Labs”), a leader in compressed gum and mints / lozenges and one of the largest contracts

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Major Depressive Disorder

Demonstrated statistically significant improvement in MADRS scores compared to active comparator (p<0.001 on primary endpoint) Rapid improvement in depressive symptoms demonstrating statistically significant superiority over active comparator withi...

Fertin Pharma’s Parent Company Acquires MedCan Pharma – Allowing Entry into Fast-growing Market for Cannabinoid Products

VEJLE, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) — Claudio Bidco A/S (the “Parent Company”), the parent company of Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of MedCan Pharma A/S (“MedCan Pharma”), a research organisation focusing on

LeddarTech ได้เซ็นสัญญาให้ Nagase Co. Ltd เป็นผู้จัดจำหน่ายแต่เพียงผู้เดียวสำหรับประเทศญี่ปุ่น

LeddarTech ได้เลือก Nagase  Co. Ltd. ให้เป็นผู้จัดจำหน่าย LiDAR สำหรับยานยนต์แต่เพียงผู้เดียวสำหรับประเทศญี่ปุ่น โดยมีผลทันที กิจกรรมความร่วมมือครั้งแรกจะเกิดขึ้นที่ CAR-ELE-JAPAN ที่กรุงโตเกียวในวันที่ 16-18 มกราคม 2019 โดยจะจัดแสดงเทคโนโลยี LiDAR แบบ Solid State ของ LeddarTech ให้แก่อุตสาหกรรมยานยนต์ เมืองควิเบก, Jan. 07, 2019 (GLOBE NEWSWIRE) — LeddarTech ผู้นำวงการอุตสาหกรรมที่ให้บริการแพลตฟอร์ม LiDAR ด้านยานยนต์ ที่สามารถใช้งานได้หลากหลายและปรับขนาดได้ วันนี้ได้ประกาศแล้วว่าทางบริษัทได้เลือกNagase & Co. Ltd. เป็นผู้จัดจำหน่ายโซลูชั่น

LeddarTech Signs Nagase & Co. Ltd as Its Exclusive Distributor for Japan

LeddarTech selects Nagase & Co. Ltd. as distributor of its mobility LiDAR products in Japan, effective now. A first collaborative event will take place at CAR-ELE-JAPAN in Tokyo on January 16-18, 2019, where they will showcase LeddarTech’s solid-state LiDAR technology

Ascension Healthcare plc: Appointment of Dr Gavin Ling as Chief Medical Officer

Ascension Healthcare plc Appointment of Dr Gavin Ling as Chief Medical Officer LONDON, January 7, 2019 – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis is

LeddarTech Delivers Production Samples of the LeddarCore LCA2 System-on-Chip for Mass-Market Automotive LiDARs

LeddarCore LCA2 production samples demonstrate enhanced LiDAR performance and resolution with a SoC and software designed to meet functional safety requirements. QUEBEC CITY, Jan. 07, 2019 (GLOBE NEWSWIRE) — LeddarTech, an industry leader providing the most versatile and scalable auto